The most popular approach for generating transgenic mammals is the direct injection of transgenes into one pronucleus of a fertilized oocyte. In the past 15 years microinjection has been successfully applied in laboratory as well as in farm animals. The frequency of transgenic founders, although highly different between the species, is efficient enough to render this technique applicable to a wide range of mammals. The expression levels and patterns of a transgene are initially influenced by the construction of the transgene. However, the overall phenotype of a transgenic organism is influenced by several genetic and environmental factors. Due to the features of this technique not all of the genetic factors can be experimentally controlled by the scientist. In this article we will emphasize some peculiarities which have to be taken into account for the successful performance of transgenesis by pronuclear microinjection. This version of the article may not be posted on a public access website for 12 months after
Introduction: methods of transgenesis
In 1981 Gordon and Ruddle introduced the term 'transgenic' in relation to mice genetically modified by transmission of foreign DNA into early embryos. Today it is applied to the characterization of an animal whose genome has been altered by the stable integration of an in vitro recombined genetic sequence. Three different methods are routinely used to generate transgenic animals: (i) transfection of early embryos with recombinant retroviruses carrying the gene of interest, (ii) pronuclear microinjection of DNA into a zygote and (iii) gene transfer into pluripotent embryonic stem (ES) cells, originally isolated from the inner cell mass of a blastocyst. Recently, a fourth method has been introduced. The transmission of foreign DNA was successfully performed by intracytoplasmatic coinjection of unfertilized mouse oocytes with sperm heads whose membranes had been disrupted (Perry et al. 1999) . If reproducible, this procedure has a potential as a method for transgenesis in the future. The aim of transgenesis is the establishment of a transgenic line. Because of the early differentiation between soma and germ line in mammals, genetic experiments have to be carried out as early as possible during ontogenesis. Therefore, preimplantation stage embryos are preferentially used (R ulicke, 1996) .
Both infection with retroviral vectors and microinjection of naked DNA are restricted to the addition of DNA sequences, whereas gene targeting in cultured ES cells can alter an endogenous gene by homologous recombination of a chromosomal locus with the transfected DNA molecule. Depending on the field of application each of these methods has its advantages as well as limitations. The importance of retroviral vectors for the generation of transgenic animals has decreased markedly and was gradually replaced by pronuclear microinjection since these vectors are limited to about 8 kb of foreign DNA. Furthermore, particular viral sequence motifs appear to suppress the expression of transgenes and the retroviral vectors are associated with a certain biohazard risk. Nevertheless, retroviral vectors have been used in avian species where the generation of transgenic animals through microinjection of naked DNA is particularly difficult and not yet routinely applicable. The ES cell technique, although of great interest in other model organisms and in livestock species, has been successfully used only in the mouse so far. Plenty of very valuable mouse mutants have been generated by this approach. They include either a loss-of-or a gain-of-function mutation. Recent developments in nuclear transfer technology could provide an alternative tool to circumvent the lack of ES cells in other mammalian species.
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The most popular approach for generating transgenic mammals is the direct injection of transgenes into one pronucleus of a fertilized oocyte. In the past 15 years microinjection has been successfully applied in laboratory as well as in farm animals. The frequency of transgenic founders, although highly different between the species, is efficient enough to render this technique applicable to a wide range of mammals. The expression levels and patterns of a transgene are initially influenced by the construction of the transgene. However, the overall phenotype of a transgenic organism is influenced by several genetic and environmental factors. Due to the features of this technique not all of the genetic factors can be experimentally controlled by the scientist. In this article we will emphasize some peculiarities which have to be taken into account for the successful performance of transgenesis by pronuclear microinjection. Experimental Physiology (2000) 85.6, 589-601.
The most popular approach for generating transgenic mammals is direct injection of transgenes into one pronucleus of a fertilized oocyte. In the last 15 years microinjection has been successfully applied in laboratory as well as in farm animals. The frequency of transgenic founders, although highly different between the species, is efficient enough to render this technique applicable to a wide range of mammals. In this article, we consider only pronuclear microinjection. We will emphasize some peculiarities, which have to be taken into account for the successful performance of transgenesis by this technique.
Pronuclear microinjection of mouse oocytes
Fertilized oocytes for microinjection are recovered from the oviduct of mated female mice after superovulation. The timing of development through the first cell cycle is shown in Fig. 1 . Mouse pronuclei are easily visible during the S-phase, the time frame when the first round of DNA replication takes place. The early female pronucleus is located not far from the second polar body where meiosis was completed after fertilization ( Fig. 2A) . About 6 h later both pronuclei show increased size and are centrally positioned (Fig. 2C) . The size and visibility of both pronuclei are mainly influenced by the oocyte, i.e. by the genotype (strain) of the female. For microinjection the male pronucleus is preferred because of its larger size and better position (Fig. 2B ).
The two pronuclei differ in their DNA structure. In oocytes, the maternal genome is packaged into chromatin. The paternal genome arrives packaged in protamines that are replaced with histones provided by the egg after fertilization (Zirkin et al. 1989) . However, there is apparently no difference in the number of transgenic offspring after injection into male or female pronuclei . For the microinjection the zygotes are immobilized with a holding pipette (Fig. 2B ). The oocytes which survive the injection procedure (about 40-90%, depending on the occupational skill) are transferred into the oviduct of a pseudopregnant surrogate mother. In our hands, about 20% of the transferred embryos develop to term and more than 20% of these live-born offspring are transgenic founders resulting in an overall yield of 1.6-3.2%.
Integration characteristics of the pronuclear injected transgenes
During microinjection about 1-2 pl of DNA solution are transferred into one pronucleus. The injection buffer typically contains 2 ng DNA ìl¢. Depending on the size of the transgene each zygote receives tens to several hundreds of linearized DNA molecules. Before chromosomal integration takes place, the injected DNA molecules recombine to large tandemly arranged concatemers. Although the dominant intermolecular recombination mechanism in mammalian cells is non-homologous, the predominant head-to-tail array strongly suggests a process of homologous recombination between multiple copies (Brouillette & Chartrand, 1987; Bishop & Smith, 1989) . The integration of pronuclear injected DNA was demonstrated by in situ hybridization in diverse regions of the mouse genome (Michalova et al. 1988; Festenstein et al. 1996; Dobie et al. 1996; Boyer et al. 1997 ). These observations supported the assumption that integration sites of transgenes are randomly distributed at unreproducible chromosomal sites. Homologous recombinations of pronuclear injected constructs with an endogenous locus is extremely infrequent (Brinster et al. 1989 ).
Only 13.2% of all founders produced in our laboratory had multiple unlinked insertions in more than one chromosomal site, suggesting that the integration of transgenes is determined by rare nuclear events. It seems reasonable to assume that illegitimate end-joining after DNA strand breaks is the main route of randomly distributed chromosomal integration of pronuclear injected transgenes. It is quite possible that the procedure of microinjection itself could induce random chromosomal damage leading to preferentially used integration sites. In addition to random DNA strand breaks, the activity of DNA topoisomerase I may play a role in the insertion process (Konopka, 1988) . As a result of so-called non-homologous or illegitimate recombination there exists probably more than one mechanism of transgene integration. Microinjected DNA can also persist for several days as free molecules. The distribution of foreign DNA between the blastomeres of an embryo was not found to be due to early T. R ulicke and U. H ubscher Exp. Physiol. 85.6 590 Figure 1 The first cell cycle of mouse development after insemination. Insemination was 13.5 h post hCG-injection for superovulation (Howlett & Bolton, 1985) . I, insemination; F, in vitro fertilization; P, start formation of pronuclei; R, DNA replication; 4, time period for microinjection; T, first cell devision; M II, meiosis II; G, gap phase (either G1 or G2); S, DNA synthesis; M, mitosis.
concatemerization (Cousens et al. 1994) . Consequently, there is ample opportunity for an integration event in single blastomeres after the first round of DNA replication. Indeed, in our laboratory almost 7.6% of all founders were genetic mosaics without germ line transmission while 31.1% were mosaics with germ line transmission . Non-homologous recombination of microinjected DNA can cause severe genetic alterations in the flanking chromosomal regions (Covarrubias et al. 1986; Wilkie & Palmiter, 1987; Kohrman et al. 1995) . Such rearrangements include deletions, duplications and translocations. This is directly opposed to the integration of retroviral vectors which merely induce a duplication of four to six base pairs of the flanking sequence (Coffin, 1996) .
Inheritance and expression of pronuclear injected transgenes unique arrangement and assortment of control elements.
Results of transgenic experiments suggested that the cisregulatory elements co-operate among each other and that the complete set of a particular gene locus must be present for an integration site-independent expression (Huber et al. 1994 (Grosveld et al. 1987; Bonifer et al. 1990 ). LCRs are short stretches of DNA, characterized by tissue-specific developmentally stable DNase-I hypersensitive sites which are able to provide an open chromatin structure to adjacent sequences even when the transgene is integrated into heterochromatic centromere regions of mouse chromosomes (Festenstein et al. 1996) . LCRs have been identified, for example, upstream of the globin gene cluster and downstream of the CD2 gene (Orkin, 1990; Lake et al. 1990 ). The chromatin opening activity and insulating properties of LCRs may additionally be influenced by certain other gene components, not always present in cDNA-and hybrid constructs (Reitman et al. 1993 ). The â_globin LCR for instance was incapable of conferring position-independent expression onto the prokaryotic marker sequences of lacZ (Guy et al. 1996) . The effect of LCRs can also be influenced by an increased copy number indicated in mice as agedependent silencing of transgene expression (Robertson et al. 1996) . Several other specific control elements have been described that can improve the expression of transgenes. Matrix/scaffold attachment regions (MARsÏSARs) are thought to be important for the organization of chromatin into functional genetic domains as a consequence of binding to the nuclear matrix (Bode et al. 1992 ). Positive effects of MAR elements onto accurate position-independent and copy number-dependent expression have been reported for transgenic mice (McKnight et al. 1992 ). Subsequent investigations, however, indicated that the positive effects of MARs on transgene expression are not universal but rather depend on the co_operation with other regulatory elements (Thompson et al. 1994; Barash et al. 1996; Neznanov et al. 1996) .
T. R ulicke and U. H ubscher Exp. Physiol. 85.6 592 Figure 3 Factors that influence the phenotype of a transgenic animal. The phenotype of an animal is the result of different genetic and non-genetic factors. Besides the background genome, direct effects of the mutation, such as the included regulatory non-coding as well as coding sequences, the integration site(s) and the number of integrated copies of a transgene, are important. Non-genetic factors are, for instance, the housing conditions, the husbandry during experiments and the microbiological environment.
Chung et al. (1993) described a novel regulatory element near the 5' boundary of the chicken â_globin gene. This element insulated transgenes in Drosophila and mice without accompanying activation or suppression effects (Chung et al. 1993; Wang et al. 1997 ). More recently, Siegfried et al. (1999) have characterized an element from the CpG island sequence (unmethylated CpG-dinucleotide rich segment of housekeeping genes) of the hamster APRT locus that may improve transgene expression due to the reduced de novo methylation of flanking sequences up to 150 bp away. Finally, two technical points have to be taken into account during the construction and preparation of linear transgenes for pronuclear injection. Firstly, prokaryotic sequences of the cloning vector have to be removed from the transgene (Townes et al. 1985; Shani, 1986) . Secondly, the injected linear constructs are prone to nuclease degradation. If a sequence loss of more than 100 bp is observed non-essential flanking regions have to be added to both sides of the construct (Kearns et al. 1995) .
cDNA or genomic sequences as source for transgenic constructs. A comprehensive knowledge of the specific gene is required in order to provide defined transgene expression in a quantitative and qualitative manner. For many interesting candidate proteins only the cDNA sequences but not the specific regulatory elements are currently available. Therefore, in transgenes using cDNA, the promoter of the gene to be mimicked is routinely combined with a heterologous enhancer, introns and polyadenylation signals. Such a transgene often results in an unpredictable expression level. Furthermore, tissue-or developmental stage-specific isoforms of (trans-) gene products may be the result of alternative splicing, a process that cannot occur when cDNA constructs were used for microinjection.
In experiments for the reconstitution of the knockout mouse for the prion protein (PrP) we have injected three different constructs of the murine PrP coding locus as transgenes (Fischer et al. 1996) . Transgenic mice harbouring 40 kbp of the complete genomic sequence including both introns and the flanking regions showed the expected PrP expression. To facilitate mutagenesis, a half genomic PrP minigene was constructed from which the large downstream intron and the downstream flanking region had been deleted (Fig. 4) . In all but one of six lines carrying this construct, PrP was correctly expressed. However, different levels of expression between the founder lines indicated a stronger sensitivity against position effects of the half-genomic construct. In contrast, all eight transgenic lines containing the cDNA construct had no detectable levels of PrP. Although we cannot exclude the loss of an unknown regulatory sequence with the upstream intron, the missing expression of the cDNA is probably due to the general lack of introns. A requirement of introns for efficient transgene expression in vivo has been described previously (Brinster et al. 1988; Whitelaw et al. 1991; Palmiter et al. 1991) . Introns can improve expression of transgenic constructs by different mechanisms. (i) Through cis-acting control elements within intron sequences.
(ii) The correct splicing process might influence transgene expression through an enhanced mRNA stability. (iii) The introduction of a generic intron that consists only of an splice donor and a splice acceptor site stimulates the expression of a transgene compared with the construct without any intervening sequence (Choi et al. 1991) . (iv) The loss of introns in cDNA constructs might lead to an unnatural sequence that effects chromatin structure, i.e. the nucleosome arrangements that may prevent transcription initiation or elongation (Liu et al. 1995) .
Pronuclear microinjection in mammals Exp. Physiol. 85.6 593 Figure 4 Constructs encoding wild-type PrP for reintroduction into Prn-p tm1 knockout mice. E1-3, exons; I1-2, introns; + or −, PrP expression of transgenic mice monitored by Northern analysis (mRNA) or Western blots (protein) of total mouse brain homogenates. The cDNA construct showed no detectable levels of prion protein and no or only very weak expression of Prn-p mRNA (+).
Most interestingly, in mice containing the half-genomic PrPminigene we found no PrP mRNA in Purkinje cells, PrP mRNA is normally abundant in wild-type as well as in PrP knockout animals that have been reconstituted with the genomic sequence. This suggested that a control element which is essential for Purkinje cell-specific PrP expression was lost within the half-genomic minigene (deletion of the 12 kbp intron and the 3' flanking region). The take home message from this work is to employ genomic constructs for generation of transgenic animals whenever possible. This should be followed by the construction of (half-) genomic minigenes in which large intronic regions are removed to facilitate transgenesis. Other strategies were also developed for construction of minigenes in order to circumvent the problems related to cDNA. Moreover, for an ectopic, conditional or inducible expression of transgenes the coding region must at least be coupled with heterologous regulatory sequences. The leakage of essential regulatory elements and the necessity of introns for RNA splicing to produce stable RNA can, for example, be solved with the insertion of the cDNA into a complete or incomplete heterologous genomic locus. In this way the viral src-kinase and the human Foamy virus env-gene were expressed in a tissue-specific manner after cloning the cDNA into the first exon of the genomic Gfap-sequence Lampe et al. 1997 ). The risk of this strategy is that artificial exons are skipped (M uller et al. 1994; Davisson et al. 1996) or that cryptic splice sites in large exon sequences are used (reviewed by Berget, 1995) . Such constraints can be bypassed with the use of an internal ribosomal entry site (IRES). Such sequences are provided by viruses from the picorna family. IRES sequences act as a ribosome landing pad and mediate the translation of di-as well as polycistronic constructs (Pelletier & Sonenberg, 1988) . This strategy allows the cDNA to be preferably positioned in the 3' untranslated region of an intact gene and lowers the risk of skipping Mountford et al. 1994; Vaulont et al. 1995) . However, since the IRES sequences are of viral origin they could become the target of host defence mechanisms.
Cloning and microinjection of large DNA fragments. If the intention is to express a transgene in its native pattern the best approach is to transfer the gene as an entire genomic locus. Since many eukaryotic genes span large regions of DNA, it excludes the use of traditional cloning vectors and standard microinjection procedures. Large transgenes can be cloned as overlapping DNA fragments and coinjected in equimolar amounts. The functional transgene can be efficiently reconstructed by homologous recombination between the DNA molecules after injection (Pieper et al. 1992; Keegan et al. 1994 ). Up to 300 kbp DNA fragments can be cloned with bacteriophage P1 artificial chromosomes (PACs) (Ioannou et al. 1994) or bacterial artificial chromosomes (BACs) (Shizuya et al. 1992) . Very large genomic loci extending several hundreds of kilobase pairs can be handled via yeast artificial chromosomes (YACs) and transferred under special conditions by pronuclear injection (Burke et al. 1987; Gnirke et al. 1993; Schedl et al. 1993a,b) . The small aperture of the microinjection needle (< 1 ìm) causes likely shearing for large DNA molecules. Low concentrations of polyamines in combination with high salt concentrations can protect DNA from shearing (Montoliu et al. 1994; Mrkic et al. 1998 ). The transmitted number of YAC molecules per injected oocyte is very low compared with injection of traditional transgenes. A DNA concentration of higher than 10 ng (ìl injection buffer)¢ may lead to a reduction in survival of the injected zygotes . Nevertheless, the resulting frequencies of transgenic offspring after YAC injection varies between 5 and 21% and is only slightly lower than after injection of hundreds of small constructs (Schedl et al. 1993a,b; Peterson et al. 1995 Peterson et al. , 1996 Heard et al. 1996; Mrkic et al. 1998 ).
Position effects on transgene expression
The expression of pronuclear injected transgenes is often highly variable between different lines containing an identical construct. This is mainly due to the random integration sites. The position effects can be caused by integration into, for example: the direct vicinity of transcription control elements of a host gene, a region of imprinting, a non-transcribed heterochromatin region and X-or Y-chromosomes.
Transcription interference and insertional mutations after random integration. The effect on transcription by cisacting endogenous regulatory DNA sequences has been demonstrated by spatial and temporal variable expression patterns in different transgenic lines with randomly integrated marker genes (Kothary et al. 1988; Allen et al. 1988 ). Position effects are exerted most strongly on those transgenes with tightly controlled promoters and that do not contain further regulatory sequences such as an enhancer (M uller et al. 1988 ), a locus control region (Grosveld et al. 1987; Palmiter et al. 1993 ) or a CpG island element (Siegfried et al. 1999) . Al-Shawi et al. (1990) demonstrated the influence of the random integration site by the isolation of a poorly expressed transgene locus from a mouse line. After reintegration of the isolated array, the secondary transgenic mice showed the expected expression level comparable to other transgenic lines harbouring the identical construct. Although difficult to prove, it is also conceivable that the activity of endogenous genes could be influenced by proximate transgenic loci. Therefore, in a knock in approach the selection marker of the targeting construct has to be removed after homologous recombination. Randomly integrated transgenes can induce insertional mutations in endogenous genes, amplified by severe alterations of flanking chromosomal regions. Although several thousand transgenic lines have been published, the number of reported insertional mutants is very low so far (reviewed by Rijkers et al. 1994) . Taking into account that only viable and fertile mutants causing strong phenotypes were identified in characterized lines, the real frequency of insertional mutations should clearly be higher.
T. R ulicke and U. H ubscher Exp. Physiol. 85.6 Genomic imprinting and de novo methylation of integrated transgenes. In a minority of transgenic lines, an epigenetic mechanism known as genomic imprinting can be observed in hemizygous animals (Reik et al. 1987; Swain et al. 1987; Sapienza et al. 1989; De Loia & Solter, 1990; Sasaki et al. 1991; Fafalios et al. 1996) . A reversible gamete-specific modification can lead to functional differences between maternal or paternal inherited transgenes in hemizygous offspring. Although many chromosomal regions of the mouse genome are involved in genomic imprinting, imprinted transgenes could so far never be exclusively attributed to a positional effect. An outstanding characteristic of transgene imprinting is the almost complete restriction of transgene inactivation to the female germ line and the influence of modifiers of the genetic background (Sapienza et al. 1989; Engler et al. 1991; Chaillet et al. 1991) . In contrast to endogenous loci, where imprinting takes part in the regulation of gene expression, the inactivation of transgenes could be a host defence mechanism against foreign DNA. The differential imprinting of alleles of specific genes in the human or mouse genome has been correlated with DNA methylation (Li et al. 1993) . Interestingly, the inactivation of transgenes by de novo methylation has frequently been observed in stable transfected cells and in transgenic mice. Constructs containing viral sequences are especially susceptible to this process (Palmiter et al. 1982; Wienhues & Doerfler, 1985; Koetsier & Doerfler, 1996; Betzl et al. 1996) . This observation supports the hypothesis that de novo DNA methylation of transgenes can also be interpreted as a defence mechanism against the activity of foreign genes in an established genome.
The influence of heterochromatin and position effect variegation on transgene expression. In mouse chromosomes, A-T rich satellite DNA is localized in heterochromatin near the centromere. Pericentric heterochromatin can be visualized as a C-band and is characterized as a late replicated and transcriptional inactive region. The capability of heterochromatin to inactivate translocated euchromatic sequences has been termed position effect variegation (PEV). Primarily observed and investigated in Drosophila (reviewed by Weiler & Wakimoto, 1995) , PEV is also present as position effect in transgenic mice. Transgene expression is usually assumed to be uniform in specific cells of a tissue. But cell-bycell analysis of transgene-encoded molecules has shown that even in mice of an established line a mosaic pattern of transgene expression exists (Elliott et al. 1995; Festenstein et al. 1996; Dobie et al. 1996; Boyer et al. 1997) . Fluorescence in situ hybridization analysis of transgene integration sites indicates that this phenomenon is observed when the transgene is located in the vicinity of pericentric heterochomatin. This position-dependent effect results in the stochastic inactivation of transgene expression in a subpopulation of cells of a particular tissue. Furthermore, the percentage of expressing cells declines with the increase in copy number within the integrated array (Dorer & Henikoff, 1994 ).
Consequences of X-and Y-chromosomal integration. Sex chromosomal integration of a transgene leads to special features regarding its inheritance and expression. The analysis of Y-chromosomal integrated transgenes is restricted to the male gender. This most specialized mouse chromosome consists predominantly of highly repeated DNA sequences with no obvious function (Bishop, 1993) . Additionally, because of its extremely late replication during mitosis, characteristic of heterochromatic segments, an optimal expression of transgenes on the mouse Y-chromosome may not be expected (Pravtcheva et al. 1994 ). X-chromosomal integrated transgenes can be subjected to modifications similar to those reported for endogenous X-linked genes. The inactivation of one X-chromosome in female mammals occurs with different schedules in different tissue lineages of the conceptus. In female extraembryonic tissues, the paternally derived X-chromosome (including the transgene) was preferentially inactivated by 3.5-4.5 days postconception. In somatic cell lineages the X-inactivation in most tissues was completed by 9.5-10.5 days postconception. Hemizygous female embryos displayed a mosaic pattern of transgene expression in about 50% of the somatic cells, most probably due to random inactivation of one X-chromosome per cell (Tagaki & Sasaki, 1975; Tan et al. 1993 ). However, it has also been reported that a transgene inserted into the X_chromosome might completely escape X-chromosome inactivation (Goldman et al. 1987 ). This could be due to integration in the X-Y pairing region, which normally escapes X-inactivation.
Multicopy array and its influence on transgene expression
The copy number of transgene concatemers varies usually between one and about 100 (Fischer et al. 1996; Magyar et al. 1996; Weissenberger et al. 1997; Raeber et al. 1999 ). However, an extreme tandem array of 1000 copies spanning an insertion of 11000 kbp has been described (Lo et al. 1992; Simon & Knowles, 1993) . There is usually no correlation found between the copy number and the expression level of transgenes. However, for transgenes harbouring LCRs, a copy number-dependent expression level was observed (Grosveld et al. 1987; Bonifer et al. 1990 ). These results indicated that each transgene copy can function as an independent regulatory unit. Silencing of transgenes in animals with high copy number is a frequent feature of pronuclear microinjection. Large tandem arrays of repeated sequences may repress efficient transcription of transgenes since inappropriate chromatin structures were induced (Simon & Knowles, 1993; Dorer & Henikoff, 1994) . A twenty-to fiftyfold reduction post integration of a high copy number array (from more than 100 to five, respectively one copy) in two independent mouse lines resulted in a marked increase in the expression level of the respective transgene. Simultaneously, chromatin compaction and DNA methylation at both recombined transgene loci were decreased (Garrick et al. 1998 ). Changes in chromatin structure after copy number reduction suggest that the reduced transcription rate per integrated Pronuclear microinjection in mammals Exp. Physiol. 85.6 transgene is not primarily due to the limitations of essential transcription factors. This also became clear by an increased gene expression level observed in several homozygous and hemizygous transgenic mice (Fischer et al. 1996; Senn et al. 2000) . Another form of (trans-) gene silencing that was unexpectedly discovered in plants, fungi and, more recently, in Drosophila, results from the interactions between homologous genes (Cogoni et al. 1996; Metzlaff et al. 1997; Pal-Bhadra et al. 1997) . By this interaction, which is called co-suppression, a transgene can inactivate its endogenous counterpart or an identical transgene that is integrated at another genomic location. Co-suppression-associated gene silencing is most probably induced by several mechanisms. Transcriptional repression in conjunction with DNA methylation and repressive chromatin structure, as well as post-transcriptional silencing by elimination of RNA products have been described in several cases (Matzke & Matzke, 1995; Baulcombe & English, 1996) . Although most transgenes apparently do not produce these effects, the progressive silencing with increasing dosage of the transgene, as, for example, found in Drosophila, reflects a biological process referred as a defence mechanism against too many copies of a certain gene (Pal-Bhadra et al. 1997 ).
Effects of the genetic background
Transgenes integrated into an established genome have to develop their function in concert with the many other genes of the cell. Pleiotropic genes and polygenic traits can describe the network of interaction between genotype and phenotype. Phenotypic variations of transgenic lines after changing the genetic background are known. These background effects were, however, only rarely classified and systematically investigated. The influence of background genes, also called modifiers, can heavily influence the characteristics of a transgenic line (Pircher et al. 1989; Baribault et al. 1994; Hsiao et al. 1995; Rozmahel et al. 1996; Nagasawa et al. 1996; Bonyadi et al. 1997) . These modifier genes can only be revealed by breeding mutations (a certain transgenic locus) onto different genetic backgrounds. To achieve this, the backcross of the transgene into defined inbred strains is very helpful. This backcross approach is primarily used to establish congenic lines. Markerassisted breeding (speed congenic) can reduce the time needed for congenic-strain production (Markel et al. 1997) . In an undefined genetic background, the polymorphism of modifier genes may be a source of variability that could exacerbate the interpretation of experimental results (Gerlai, 1996; Wolfer et al. 1997 ). On the other hand, the recognition of a modifier gene can be an interesting reference for a better understanding of an observed phenotype or can improve a particular mouse model.
Strategies for site-specific and single-copy transgene integration
The possibility of a directed transgene integration into a neutral chromosomal site would make the pronuclear injection results more reproducible and comparable. Position effects on transgene expression caused by random integration sites thus could be eliminated and could be combined with the ability to avoid undesired insertional mutations. To achieve a directed transgene integration, the two sitespecific recombination systems of Cre-loxP and of FLP-FRT were thought to be helpful. The simplicity of these experimental systems has led to their widespread use as a tool for in vivo DNA recombination. For example, Cre-recombinase was successfully used to delete loxP-flanked fragments of chromosomal integrated transgenes (Lakso et al. 1992 ). Although recombination is a reversible process, the integration (intermolecular recombination) is about two orders of magnitude less efficient than the deletion (intramolecular recombination) (Abremski et al. 1983 ). After site-specific recombination, the integrated DNA fragment is flanked by two loxP sites and therefore promptly excised as long as the Cre-recombinase is present. Several strategies were tried to generate a stable insertion product. Most promising was the use of mutated loxP sites combined with a transient provision of Cre-recombinase to curtail the post-integration recombinase activity (Senecoff, 1988; Fukushige & Sauer, 1992; Baubonis & Sauer, 1993; Albert et al. 1995) . Because of very low efficiency this strategy has proved so far to be inapplicable even when it is combined with pronuclear injection (T. R ulicke, unpublished results). Araki et al. (1997) succeeded in producing a Cremediated single copy integration of transgenes into a mutated chromosomal loxP site in murine ES cells. However, the recombination frequency obtained was only comparable to that of gene targeting via homologous recombination. A similar approach by using mutated FRT sites in E. coli reduced the recombination efficiency by a factor of 100 compared with the wild-type . Thus, the enhanced stability of integration by the use of mutated loxP or FRT sites is probably outweighed by a very inefficient forward recombination. Targeting a single copy of a transgene to a specific location in the mouse genome can be performed with the help of homologous recombination in ES cells. The transgenic sequence is transferred as part of a targeting construct to the target endogenous sequence. Particularly useful for this strategy is the mutated Hprt locus: homologous recombination events are directly selectable and the ubiquitously expressed locus provides an optimal chromosomal environment for transgene expression (Bronson et al. 1996) . The targeting frequency seems to be insensitive to the length of non-homologous DNA in the vector, rendering this strategy absolutely available for the site-directed integration of classical transgenic constructs (Mansour et al. 1990 ).
Assessing transgenic animals
There is continuous and remarkable development in transgenic technology, particularly in the quality of transgenes and experimental approaches. Nevertheless, the consequences of experimentally induced mutations cannot be completely predicted. This is especially true for the majority of transgenic animals that are generated by pronuclear injection. Even T. R ulicke and U. H ubscher Exp. Physiol. 85.6 though our experience shows that the welfare of the majority of transgenic animals is not noticeably affected, randomly integrated foreign DNA may increase the risk of disturbing the normal physiology of an animal. The resulting phenotypic changes may be crucial to the animals' welfare already during breeding and maintenance of a transgenic line. Apparent and relevant phenotypic changes can only be determined after a careful and comprehensive assessment (Mertens & R ulicke, , 2000 . This monitoring for phenotypic changes should be done as early as possible, namely during the establishment of a new transgenic line. Since each transgenic line produced by pronuclear injection is unique, it has to be carefully assessed separately by specialists.
Outlook
Pronuclear DNA injection has enabled the scientific community world wide to selectively add defined genes of choice into the germ line of laboratory as well as farm animals. Many experiments with transgenic animals confirmed that transgenesis can provide new insight into many aspects of mammalian life, development and diseases. Moreover, improved strategies allow the modification and tightly controlled regulation of transgenes after chromosomal integration. Most impressively, the conditional or inducible activities of transgenes can be controlled in a specific spatiotemporally regulated manner and provide great advance in transgenic animal technology. The use of conditional and inducible transgenic systems can permit the study of a phenotype containing or lacking the transgene product at any given developmental stage of the same individual. This could enable experimental approaches that can either focus on specific time points or in specific tissues during ontogeny, on effects of the duration of transgene expression and on the reversibility of induced phenotypes. These strategies can take advantage, for example, of prokaryotic recombination and transcriptional activation systems such as Cre-loxP and tetRÏtetO (Hoess & Abremski, 1985; Gossen & Bujard, 1992) . Recently, the Cre-system has been developed as a standard genetic tool. The expression of Cre-recombinase, for example, can be restricted to a given cell type by the use of a tissue-specific promoter to dictate specific transgene expression or suppression (For details see the Cre-transgenic database: www.mshri.on.nagyÏCre-pub.html). Other strategies to utilize steroid receptors and their associated proteins are being tested in mice. To accomplish tissue-and, additionally, time-specific transgene regulation, the Cre enzyme can be expressed as a fusion protein with a mutant estrogen receptor ligand-binding domain which is exclusively responsive to the synthetic oestrogen antagonist tamoxifen (Schwenk et al. 1998 ). The tetracycline-regulated system is not yet fully developed to guarantee success in each case. Some of the difficulties may relate to variations between different cell types in their interaction with tetracycline, as found in in vitro studies (Ackland-Berglund & Leib, 1995) . Moreover, mammalian cells could be an inappropriate environment for processing the bacterial tetR gene. It remains to be seen whether this and other systems that are currently under investigation will be more robust for application in transgenic animals. Controlled simultaneous andÏor independent expression of one or several transgenes simultaneously and independently in the same organism is a powerful tool to study the gene function and its physiological consequences. Novel methods and systems for the creation of transgenic animal models shows considerable promise and will broaden their scope of application. As discussed in this review, it is also necessary to bear in mind that highly sophisticated transgenic strategies that are based on pronuclear injection can be subjected to many possible influences.
